🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well giving bevacizumab, radiation therapy,...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2006-07-25
Trial ID
NCT00321685
Preoperative chemoradiation leads to increased pelvic control and overall s...
Status
Completed
Location
UT M. D. Anderson Cancer Center
Start Date
2005-02
Trial ID
NCT00113230
Treatments Being Tested
\*\*Brief Summary\*\* The goal of this clinical trial is to learn whether ...
Status
Recruiting
Location
The Second Affiliated Hospital,School of Medicine,Zhejiang University
Start Date
2025-12-01
Trial ID
NCT07670026
Treatments Being Tested
To explore the efficacy of incorporating neoadjuvant immunotherapy into neo...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2023-11-01
Trial ID
NCT06093438
Treatments Being Tested
Bevacizumab has become the standard of care of recurrent glioblastoma based...
Status
Unknown
Location
Taichung Veterans General Hospital
Start Date
2015-08-01
Trial ID
NCT03225963
Treatments Being Tested
The aim of the Phase 4 study is to test the scale structure, reliability, r...
Status
Completed
Location
Center for Clinical Studies, University Hospital Regensburg
Start Date
2016-04-01
Trial ID
NCT02745691
Treatments Being Tested
Phase II pilot study of a preoperative induction chemotherapy in combinatio...
Status
Completed
Location
Hospital BHB St. Veit/Glan, Surgery
Start Date
2011-10
Trial ID
NCT01434147
This is a multicenter, prospective, randomized phase II trial designed to e...
Status
Not Yet Recruiting
Location
Department of Colorectal Surgery in Changhai Hospital
Start Date
2025-10
Trial ID
NCT07134218
Treatments Being Tested
In a single-center, prospective, phase II study (ClinicalTrials registratio...
Status
Recruiting
Location
The First Affiliated Hospital of Wenzhou Medical University
Start Date
2025-12-01
Trial ID
NCT07347951
SMARCA4 mutation is clinically known to be an independent poor prognostic f...
Status
Not Yet Recruiting
Location
The 900th Hospital of the Joint Logistic Support Force, PLA, Fuzhou, Fujian, China, 350025
Start Date
2025-08-20
Trial ID
NCT07093762
Treatments Being Tested